Table 4 Total number of viable, equivocal and nonviable observations in the second follow-up after 6 months
Count | % | |
|---|---|---|
Therapy response 2 | ||
LR-TR viable | 16 | 16.0 |
LR-TR equivocal | 8 | 8.0 |
LR-TR nonviable | 76 | 76.0 |
Therapy response 2 (equivocal as viable) | ||
LR-TR viable + equivocal | 24 | 24.0 |
LR-TR nonviable | 76 | 76.0 |
Therapy response 2 (equivocal as nonviable) | ||
LR-TR viable | 16 | 16.0 |
LR-TR nonviable + equivocal | 48 | 84.0 |
Typical arterial enhancement 2 | ||
Yes | 12 | 12.0 |
No | 88 | 88.0 |
Atypical Arterial enhancement 2 | ||
Yes | 4 | 4.0 |
No | 96 | 96.0 |
Good response specific enhancement 2 | ||
No | 100 | 100.0 |
Delayed washout 2 | ||
Yes | 12 | 12.0 |
No | 44 | 88.0 |